John Crowley Quotes
John Crowley is an American author of fantasy, science fiction, and mainstream fiction. He is best known for his 1980 novel Little, Big, which won the World Fantasy Award for Best Novel and was nominated for the Nebula Award for Best Novel. He has also written the four-volume Ægypt sequence, the fou…Read More
John Crowley is an American author of fantasy, science fiction, and mainstream fiction. He is best known for his 1980 novel Little, Big, which won the World Fantasy Award for Best Novel and was nominated for the Nebula Award for Best Novel. He has also written the four-volume Ægypt sequence, the four-volume novel sequence The Solitudes, and the novel Engine Summer. Crowley has won the World Fantasy Award for Life Achievement, the Bram Stoker Award for Lifetime Achievement, and the American Academy of Arts and Letters Award in Literature.Read Less
John Crowley is an American author of fantasy, science fiction, and mainstream fiction. He is best known for his 1980 novel Little, Big, which won the World Fantasy Award for Best Novel and was nominated for the Nebula Award for Best Novel. He has also written the four-volume Ægypt sequence, the four-volume novel sequence The Solitudes, and the novel Engine Summer. Crowley has won the World Fantasy Award for Life Achievement, the Bram Stoker Award for Lifetime Achievement, and the American Academy of Arts and Letters Award in Literature.
3 Inspiring John Crowley Quotes
John Crowley Career Highlights
- Crowley’s career in the biotechnology industry began in 1998 when he joined Bristol-Myers Squibb as a marketing and sales representative.
- In 2000, he joined Novazyme Pharmaceuticals as a senior director of business development, where he played a key role in the company’s acquisition by Genzyme Corporation.
- In 2003, Crowley co-founded Amicus Therapeutics with his brother, seeking to develop treatments for rare and orphan diseases.
- Under his leadership, Amicus Therapeutics has grown into a publicly traded company with a market capitalization of over $2 billion.
- In 2010, Crowley was named the Ernst & Young Entrepreneur of the Year in the Life Sciences category for New Jersey.
- In 2017, he was appointed to the board of directors of the Biotechnology Innovation Organization (BIO), the world’s largest biotechnology trade association.
Key Contributions by John Crowley
- Crowley’s most significant contribution has been in the development of treatments for rare and orphan diseases. He has been a strong advocate for patients with these conditions, often referred to as “forgotten diseases,” and has dedicated his career to finding cures for them.
- He has also been instrumental in securing funding for Amicus Therapeutics, raising over $1 billion in capital through various financing rounds and partnerships.
- Crowley’s leadership has led to the successful development and approval of multiple treatments for rare diseases, including Galafold, a treatment for Fabry disease, and Migalastat, a treatment for Pompe disease.
- He has also been a vocal advocate for policies that support the development of treatments for rare diseases, such as the Orphan Drug Act and the 21st Century Cures Act.
What Sets John Crowley Apart
- One of the key factors that sets John Crowley apart is his personal connection to the rare disease community. Two of his children were diagnosed with Pompe disease, a rare and often fatal neuromuscular disorder, which motivated him to enter the biotechnology industry and find a cure for the disease.
- Crowley’s determination and resilience in the face of personal and professional challenges have been crucial in his success. Despite facing numerous setbacks and failures, he has remained committed to his goal of finding treatments for rare diseases.
- He is also known for his strong leadership skills and ability to inspire and motivate his team. He has created a culture of innovation and collaboration at Amicus Therapeutics, which has been essential in the company’s success.
Takeaways
- John Crowley’s career highlights and key contributions demonstrate his passion for finding treatments for rare diseases and his dedication to making a difference in the lives of patients.
- His success in the biotechnology industry serves as an inspiration for aspiring entrepreneurs and leaders, showcasing the importance of perseverance and determination in achieving goals.
- Crowley’s personal connection to the rare disease community highlights the impact that individuals can have when they are personally invested in a cause.
- His leadership style and ability to overcome challenges make him a role model for those looking to make a difference in the world of biotechnology and beyond.
Other People
Writer/Author
Author
1882 - 1956
Author
· Canada
1843 - 1919
Author
1933
